Treatment Rationale and Study Design for Clinical Trial on the Efficacy of UFT/LV for Stage II Colorectal Cancer With Risk Factors for Recurrence (JFMC46-1201)

Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2015.05.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Sub-Classification of Stage II Colorectal Cancer Based on Clinicopathological Risk Factors for Recurrence

Surgery Today
MedicineSurgery
2013English

Safety of UFT/LV and S-1 as Adjuvant Therapy for Stage III Colon Cancer in Phase III Trial: ACTS-CC Trial

British Journal of Cancer
Cancer ResearchOncology
2012English

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

Randomized Phase III Trial Comparing Surgery Alone to UFT + PSK for Stage II Rectal Cancer (JFMC38 Trial)

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2017English

Clinicopathologic Factors Affecting Recurrence After Curative Surgery for Stage I Colorectal Cancer

Journal of the Korean Society of Coloproctology
2012English

Risk Factors for Diagnosis of Colorectal Cancer at a Late Stage: A Population-Based Study

Journal of General Internal Medicine
Internal Medicine
2018English

A High Preoperative Carbohydrate Antigen 19-9 Level Is a Risk Factor for Recurrence in Stage II Colorectal Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2016English

Serum Carcinoembryonic Antigen Trends for Diagnosing Colorectal Cancer Recurrence in the FACS Randomized Clinical Trial

British Journal of Surgery
Surgery
2018English

Study of Multiple Factors for Prognosis and Recurrence After Hepatic Resection for Metastasis From Colorectal Cancer.

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy